Delivery Order SPE2DE21D7020-SPE2D626F11SE
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,094.40 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 17, 2025. This fixed-price contract with economic price adjustment was awarded on December 10, 2025, and is issued without a small business set-aside. The delivery order is placed against Boston Scientific's single-award Blanket Purchase Agreement with the Defense...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on December 5, 2025, with an ultimate completion date of December 12, 2025, is designated as a fixed-price delivery order with economic price adjustment provisions. This award is issued without small business set-aside restrictions, allowing Boston Scientific to compete on an unrestricted...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,997.14 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of January 13, 2026. This fixed-price contract with economic price adjustment provisions was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The delivery order is issued against a larger single-award Blanket Purchase...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,475.10 by the Defense Health Agency's Medical Supply Chain division under a fixed-price contract with economic price adjustment provisions. The award, issued on January 5, 2026, with an ultimate completion date of January 12, 2026, represents a continuation of Boston Scientific's role as a critical supplier of specialized medical devices to federal healthcare entities. This...
- Boston Scientific Corp has been awarded a delivery order valued at $1,295.63 under a Defense Health Agency Medical Supply Chain Blanket Purchase Agreement, with a completion deadline of November 7, 2025. This fixed-price contract with economic price adjustment authority represents delivery order activity against Boston Scientific's established single-award BPA with the Defense Health Agency, valued at $750,000 and effective through March 30, 2030. The contract, which carries no small business...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $16,425.00 by the Defense Health Agency's Medical Supply Chain division on January 12, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes fixed-price pricing with economic price adjustment and was awarded without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This delivery order is issued against Boston...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,684.30 by the Defense Health Agency's Medical Supply Chain division on December 29, 2025, with an ultimate completion date of January 6, 2026. This fixed-price delivery order with economic price adjustment authority carries no small business set-aside and represents a task order issued against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency for...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a $1,476.55 fixed-price delivery order (Contract No. 4570394377) by the Defense Health Agency's Medical Supply Chain on January 5, 2026, with an ultimate completion date of January 12, 2026. This delivery order is issued against Boston Scientific's single-award Blanket Purchase Agreement valued at $750,000 with a ceiling through March 30, 2030, which designates the company as the sole supplier of radiation treatment...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a $1,496.60 fixed-price delivery order (Contract No. 4570506310, "MAMBA FLEX 135") by the Defense Health Agency's Medical Supply Chain division on January 14, 2026, with an ultimate completion date of January 22, 2026. This delivery order was issued without a small business set-aside and carries an economic price adjustment provision. The award represents delivery order activity...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $19,920.74 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of November 18, 2025. This delivery order, issued on November 10, 2025, is a non-set-aside award issued without small business restrictions. The contract utilizes fixed-price pricing with economic price adjustment terms and represents a task order issued against Boston...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F11SEDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $1,024.00 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of January 23, 2026. This fixed-price contract with economic price adjustment was issued on January 15, 2026, and will be performed at the company's headquarters in Marlborough, Massachusetts. The delivery order was awarded without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This award is issued against Boston Scientific's existing single-award Blanket Purchase Agreement with the Defense Health Agency valued at $750,000 and expiring March 30, 2030, which designates the company as the sole supplier for radiation treatment devices. As a global medical technology company, Boston Scientific supplies specialized medical devices to federal healthcare entities, including the Department of Veterans Affairs and Defense Health Agency. Through this BPA and related delivery orders, the company fulfills supply requirements for radiation oncology equipment such as yttrium-90 glass microspheres and related radiopharmaceuticals for cancer treatment across military healthcare facilities and Veterans Affairs medical centers. The company's extensive portfolio of federal contracts demonstrates the government's confidence in Boston Scientific's capability to maintain supply chain continuity for critical specialized medical devices across the defense and veterans healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/14/26 |